Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a smartphone app beat a paper diary for migraine management?

NCT ID NCT04984720

Symptom relief Sponsor: All India Institute of Medical Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study compares a smartphone app that tracks migraine attacks, sends pill reminders, and includes a community blog against a traditional paper diary. About 400 adults with migraine will use both methods in a crossover design. The goal is to see if the app reduces headache impact and improves medication adherence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Smartphone-based digital application with migraine tracking, pill reminders, and community blog
What this could lead to
If effective, this app could offer a simple, accessible way for people with migraine to better manage their condition and improve quality of life.
What could go wrong
This is a single-center trial, and results may not apply to all migraine patients. The app's benefits over a paper diary may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

403 people

The number who actually took part.

Started

Jul 2021

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients attending neurology OPD. * At least 18 years of age; any gender. * Episodic or chronic migraine diagnosed (using International Classification of Headache Disorders-3 (ICHD-3) . * No modifications to the prophylactic therapy or acute pain relief medications is planned over the next 3 months. * Can read and write in Hindi or English easily. * Have an Android/iOS smart phone in which digital application can be installed and who knows how to operate smart phone. * Ready to provide consent and willing to adhere to protocol and comply with follow up visits. * No major neurological or systemic medical condition that reduces life expectancy to less than 1 year based on clinical prediction scores. Exclusion Criteria: * Not willing to adhere to protocol. * Not willing to provide consent. * Inability or unwillingness to complete diary recording. * Patients with Medication over use headache ( as per ICHD -3). * Other primary headaches and secondary headache disorders.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Migraine are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medication Adherence migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Migraine

Contacts and locations

Locations

  • All India Institute of Medical Sciences, New Delhi

    New Delhi, National Capital Territory of Delhi, 110029, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.